AKBA · Company research
Akebia Therapeutics, Inc. (AKBA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 0.8785 | $241,617,981.86 | 86069981.8614 | 40.0500000000000000 | — | — | 4.9181318568107800 | 9.6577656831641218 | 98.78085930556009808592 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.